EUnetHTA releases guideline on relative effectiveness Novadiscovery, a leading company in R&D risk management and health care predictive modeling, is pleased to announce its Effect Model approach gains recognition in the context of relative effectiveness analysis of pharmaceuticals. A critical step towards the widespread adoption of our methodology to base market access, pricing and reimbursement decisions. eunethta.eu/sites/5026.fedimbo.belgium.be/files/Applicability.pdf
Posted on: Thu, 13 Jun 2013 09:23:55 +0000
Recently Viewed Topics
© 2015